- Acne
- Actinic Keratosis
- Aesthetics
- Alopecia
- Atopic Dermatitis
- Buy-and-Bill
- COVID-19
- Case-Based Roundtable
- Chronic Hand Eczema
- Drug Watch
- Eczema
- General Dermatology
- Hidradenitis Suppurativa
- Melasma
- NP and PA
- Pediatric Dermatology
- Pigmentary Disorders
- Practice Management
- Precision Medicine and Biologics
- Prurigo Nodularis
- Psoriasis
- Psoriatic Arthritis
- Rare Disease
- Rosacea
- Skin Cancer
- Vitiligo
- Wound Care
Video
Aesthetic Business as Usual Amid COVID-19
Dr. Randolph Waldman shares details about his overall high patient retention rate and continuing demand for procedures during the ongoing COVID-19 pandemic.
The aesthetic industry was gripped by fears of a financial fallout as a result of COVID-19, but those fears were unfounded in his practice, according to Randolph Waldman, MD.
In this interview with Aesthetic Authority, Dr. Waldman discusses unpredicted levels of patient retention in his practice and others around the country.
Unlike many other specialties, aesthetic medicine is continuing to experience a steady stream of patients for surgical and nonsurgical procedures during the pandemic.
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
